Federal contract award
75N93024C00028
LONG-ACTING ANTIVIRAL IMPLANT FOR THE TREATMENT OF HCV
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | SMALL BUSINESS SET ASIDE - TOTAL |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $300.0K |
| Current contract value | $300.0K |
| Potential contract value / ceiling | $300.0K |
| Start date | Sep 1, 2024 |
| Current end date | Aug 31, 2025 |
| Potential end date | Aug 31, 2025 |
| Latest award activity | Aug 28, 2024 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 28, 2024 | 0 | $300.0K | LONG-ACTING ANTIVIRAL IMPLANT FOR THE TREATMENT OF HCV |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.